Key result
Surgery and R-CHOP for primary cardiac DLBCL ends in fatal heart failure at 6 months.
Why the study?
Primary cardiac lymphomas are rare, have sudden onset, rapid progression, and high mortality, necessitating detailed clinical and pathological characterization.
Population
1 64-year-old male patient with primary cardiac diffuse large B-cell lymphoma
Design
Case report
Authors
Loading...
Documents rare primary cardiac DLBCL presentation; extends sparse case literature but leaves optimal management strategies open.
Case Report (n=1)
No
Primary cardiac diffuse large B-cell lymphoma is a rare, aggressive malignancy that can present as heart failure and carries a poor prognosis despite surgical resection and chemotherapy.
Jiang et al. (2023) conducted a case report in Primary cardiac diffuse large B-cell lymphoma (n=1). Surgical resection and R-CHOP chemotherapy was evaluated on Clinical outcome. A 64-year-old male with primary cardiac diffuse large B-cell lymphoma underwent surgical resection and R-CHOP chemotherapy but died of heart failure 6 months postoperatively.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: